INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Ms. Shobana Kamineni (DIN - 00003836) has resigned as a Director of the Company. This is for your information and records. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Disclosure Of Material Impact Of COVID-19 Pandemic On The Company
With regard to the disclosure requirements set out under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated 20th May, 2020, kindly find below the COVID-19 related impact on the business and operations of the Company. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the provisions of Regulation 39 of the the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a statement of Duplicate Share Certificate issued by the Company in respect of Share Certificates reported to be lost by the shareholder. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Clarification
With reference to Movement in Volume, Indraprastha Medical Corporation Ltd has submitted to BSE a copy of Clarification is enclosed. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Retirement
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Ajay Kumar Singhal has completed his tenure as Vice President cum Company Secretary of the Company, effective from the close of the business hours on 15th July, 2020. This is for your information and records. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 013130 Name of the Signatory :- AJAY KUMAR SINGHALDesignation :- Company Secretary and Compliance Officer INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the provisions of Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that we have received request from a shareholder for issue of duplicate share certificates in lieu of share certificates reported lost, as per details enclosed. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholding for the Period Ended June 30, 2020
Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window
Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st July, 2020 till 48 hours after the declaration of financial results for the quarter ending 30th June, 2020. This is for your information and record. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Clarification sought from Indraprastha Medical Corporation Ltd
The Exchange has sought clarification from Indraprastha Medical Corporation Ltd on June 24, 2020, with reference to Movement in Volume.The reply is awaited.